CompoAtlas

Juice PLUS®+KOŠĻĀJAMĀS TABLETES DĀRZEŅU MAISĪJUMS (2020.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000104/2020
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
The Juice Plus + Company GmbH
Manufacturer
F. Hunziker + Co AG
Origin
Vācija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
2-4 tabletes
Published pack size
košļājamās tabletes pa 2,5 g
Published packaging
120 tabletes

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
C VITAMĪNSvitamins ; C VITAMĪNS ; 56 ; mgVitamine CVitamin or mineral
E VITAMĪNSvitamins ; E VITAMĪNS ; 11,4 ; mg α-TEVitamine EVitamin or mineral
A VITAMĪNSvitamins ; A VITAMĪNS ; 233 ; μg REVitamine AVitamin or mineral
Brokoļu virszemes daļas pulverisplants ; Brokoļu virszemes daļas pulveris ; Brassica oleracea var. italica ; 48 ; mgbrassica oleraceaPlant
Burkānu sakņu pulverisplants ; Burkānu sakņu pulveris ; Daucus carota ; 308 ; mgBêta-carotèneVitamin or mineral
Pētersīļu lapu pulverisplants ; Pētersīļu lapu pulveris ; Petroselinum crispum ; 176 ; mgpetroselinum crispumPlant
Spinātu lapu pulverisplants ; Spinātu lapu pulveris ; Spinacia oleracea ; 20 ; mgspinacia oleraceaPlant
Lapu kāpostu (kale kāpostu) lapu pulverisplants ; Lapu kāpostu (kale kāpostu) lapu pulveris ; Brassica oleracea var.acephala ; 36 ; mgbrassica oleraceaPlant
Tomātu augļu pulverisplants ; Tomātu augļu pulveris ; Lycopersicon esculentum ; 12 ; mglycopersicon esculentumPlant
Ķiploka sīpoliņu pulverisplants ; Ķiploka sīpoliņu pulveris ; Allium sativum ; 6 ; mgallium sativumPlant
Galviņkāposta lapu pulverisplants ; Galviņkāposta lapu pulveris ; Brassica oleracea capitata ; 22 ; mgbrassica oleraceaPlant
Cukurbiešu sakņu pulverisplants ; Cukurbiešu sakņu pulveris ; Beta vulgaris ; 16 ; mgbeta vulgarisPlant
Melnā plūškoka augļu pulverisplants ; Melnā plūškoka augļu pulveris ; Sambucus nigrasambucus nigraPlant
Citronu mizas ekstraktsplants ; Citronu mizas ekstrakts ; Citrus limoncitrus limonPlant
Tapiokas sīrupsotherIngredients ; Tapiokas sīrupsNot recognisedRole not identified
Rezistentais maltodekstrīnsotherIngredients ; Rezistentais maltodekstrīnsNot recognisedRole not identified
Cukurniedru cukursotherIngredients ; Cukurniedru cukursNot recognisedRole not identified
Pektīns (E440)otherIngredients ; Pektīns (E440)Listed as food additive E 440 (EU Union list)Role not identified
Citronskābe (E330)otherIngredients ; Citronskābe (E330)Listed as food additive E 330 (EU Union list)Role not identified
Rīsu kliju pulverisotherIngredients ; Rīsu kliju pulverisNot recognisedRole not identified
Pienskābe (E270)otherIngredients ; Pienskābe (E270)Listed as food additive E 270 (EU Union list)Role not identified
Antocianīni (E163)otherIngredients ; Antocianīni (E163)Listed as food additive E 163 (EU Union list)Role not identified
AromatizētājiotherIngredients ; AromatizētājiNot recognisedRole not identified
Nātrija citrāti (E331)otherIngredients ; Nātrija citrāti (E331)Listed as food additive E 331 (EU Union list)Role not identified
Kokosriekstu eļļaotherIngredients ; Kokosriekstu eļļaNot recognisedRole not identified
Karnaubvasks (E903)otherIngredients ; Karnaubvasks (E903)Listed as food additive E 903 (EU Union list)Role not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Šveice

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Burkānu sakņu pulveris
    Read the warning, when it applies and the studies cited

    CARROT - DAUCUS CAROTA SUBSP. SATIVUS

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 6,000 μg of beta-carotene, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are a tobacco smoker (Touvier et al. 2005; Omenn et al. 1996; ATBC 1994).

    Sources cited by Health Canada (3)
    • ATBC (Alpha-tocopherol, beta-carotene cancer prevention) study group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The New England Journal of Medicine1994;330(15):1029-1035.
    • Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine 1996;334(18):1150-1155. PubMed Randomised trial
    • Touvier M, Kess E, Clavel-Chapelon F, and Boutron-Rualt MC. Dual association of beta- carotene with risk of tobacco-related cancers in a cohort of French women. Journal of the National Cancer Institute 2005;97(18):1338-1344. PubMed

    Health Canada monograph dated 30 January 2026

  • Ķiploka sīpoliņu pulveris
    Read the warning, when it applies and the studies cited

    Garlic - Allium sativum

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 30 January 2026

  • Melnā plūškoka augļu pulveris
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    Sources cited by Health Canada (1)
    • Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
    • Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Juice PLUS®+KOŠĻĀJAMĀS TABLETES DĀRZEŅU MAISĪJUMS (2020.)”, https://compoatlas.com/en/supplements/latvia/8594-juice-plus-koslajamas-tabletes-darzenu-maisijums-2020, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line